Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Total Liabilities of $222.9 million for Q1 2026, up 6.94% year-over-year from $208.4 million in Q1 2025, and little changed quarter-over-quarter from $222.2 million in Q4 2025.
Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Total Liabilities for 17 consecutive years, with $222.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 6.94% year-over-year to $222.9 million; the TTM figure through Mar 2026 stood at $222.9 million (up 6.94% YoY), while the FY2025 annual figure was $222.2 million, up 3.56% from the prior year.
- Total Liabilities held at $222.9 million in Q1 2026 per LMAT's latest filing, from $222.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $222.9 million in Q1 2026 and bottomed at $34.7 million in Q1 2022.
- Historically, Total Liabilities has averaged $104.3 million across 5 years, with a median of $45.5 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities sank 50.37% — and 2025, when it jumped 393.5%.
- Lemaitre Vascular's Total Liabilities stood at $42.3 million in 2022, then increased by 15.62% to $48.9 million in 2023, then jumped by 338.9% to $214.5 million in 2024, then advanced by 3.56% to $222.2 million in 2025, then rose by 0.33% to $222.9 million in 2026.
- Business Quant data shows LMAT's Total Liabilities at $222.9 million in Q1 2026, $222.2 million in Q4 2025, and $219.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 220.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 220.21 Mn |
| Mar 31, 2026 | 222.90 Mn |
| Dec 31, 2025 | 222.17 Mn |
| Sep 30, 2025 | 219.15 Mn |
| Jun 30, 2025 | 214.91 Mn |
| Mar 31, 2025 | 208.43 Mn |
| Dec 31, 2024 | 214.53 Mn |
| Sep 30, 2024 | 45.95 Mn |
| Jun 30, 2024 | 43.55 Mn |
| Mar 31, 2024 | 45.45 Mn |
| Dec 31, 2023 | 48.88 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 42.64 Mn |
| Mar 31, 2023 | 40.70 Mn |
| Dec 31, 2022 | 42.28 Mn |
| Sep 30, 2022 | 40.80 Mn |
| Jun 30, 2022 | 41.39 Mn |
| Mar 31, 2022 | 34.67 Mn |
| Dec 31, 2021 | 38.65 Mn |
| Sep 30, 2021 | 40.43 Mn |